- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01198288
Effects of Home-based Pulmonary Rehabilitation in Patients With Severe or Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Randomised Controlled Trial on the Effects of Home-based Pulmonary Rehabilitation in Patients With Severe or Very Severe COPD
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Contact
- Name: Marta Lazzeri
- Email: presidenza@arirassociazione.org
Study Locations
-
-
Varese
-
Busto Arsizio, Varese, Italy
- Recruiting
- Unità di pneunologia, Ospedale di Busto Arsizio
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Severe COPD (FEV1/FVC < 70% and FEV1 < 50% pred.) associated to hypoxaemic chronic respiratory insufficiency (PaO2 < 60mmHg) or
- Very severe COPD (FEV1/FVC < 70% and FEV1 < 30% pred.)
With the following characteristics:
- no signs of lung restriction (TLC≥80%)
- clinically stable for at least the last four weeks
- MRC ≥ 2
- no participation to PR programmes in the last year
FEV1= Forced expiratory volume in the 1st second FVC= Forced vital capacity TLC= Total Lung Capacity PaO2= Partial pressure of arterial oxygen
Exclusion Criteria:
- - Muscular-skeletal impairment that could limit the patient's participation to the exercise programme;
- Cognitive impairment that could limit the patient's participation to the activities of education and exercise, as assessed by the Mini Mental State (MMS) test <26;
- Malignancies
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard Care
Drugs for COPD (as prescribed), oxygen therapy if needed*, check-up by the general practitioner and/or respirologist as usual. Educational leaflet regarding optimization of oxygen therapy and drugs; Benefits of physical activity and proposal of a programme of exercise training; Energy conservation techniques; Nutritional counselling; Activity of daily Living (ADL) diary; Prevention and management of acute exacerbation Monthly phone call with the aim of verifying:
|
As describe in the standard care arm
|
Experimental: domiciliary rehabilitation
Same as the standard care group plus 10 (ten) home-based visits supervised by a specifically trained respiratory therapist (education+exercise training) Autonomous home-based programme: The patients will be given instructions and training in order to continue the exercise training programme on the days the respiratory therapist is not visiting them. Counselling addressed at the outdoor activities. |
a respiratory rehabilitation programme at the patient home
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
meters as per walking test performance
Time Frame: 8 weeks
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life
Time Frame: 6 months
|
6 months
|
|
Quality of life
Time Frame: 12 months
|
12 months
|
|
Quality of life
Time Frame: 8 weeks
|
8 weeks
|
|
Bode index
Time Frame: 8 weeks
|
This index is a combination of walking test result, Body Mass Index and respiratory measurement
|
8 weeks
|
dyspnea
Time Frame: 8 weeks
|
8 weeks
|
|
relapses
Time Frame: 8 weeks
|
8 weeks
|
|
services utilization
Time Frame: 8 weeks
|
visits to the GP or Pneumologist that were not planned, hospital visits (emergency room )
|
8 weeks
|
meters as per walking test performance
Time Frame: 6 months
|
6 months
|
|
Bode index
Time Frame: 6 months
|
This index is a combination of walking test result, Body Mass Index and respiratory measurement
|
6 months
|
dyspnea
Time Frame: 6 months
|
6 months
|
|
relapses
Time Frame: 6 months
|
6 months
|
|
services utilization
Time Frame: 6 months
|
visits to the GP or Pneumologist that were not planned, hospital visits (emergency room )
|
6 months
|
meters as per walking test performance
Time Frame: 12 months
|
12 months
|
|
Bode index
Time Frame: 12 months
|
This index is a combination of walking test result, Body Mass Index and respiratory measurement
|
12 months
|
dyspnea
Time Frame: 12 months
|
12 months
|
|
relapses
Time Frame: 12 months
|
12 months
|
|
services utilization
Time Frame: 12 months
|
visits to the GP or Pneumologist that were not planned, hospital visits (emergency room )
|
12 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 01 (Miami VAHS)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Kırıkkale UniversityRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on Standard Care
-
Evandro Chagas Institute of Clinical ResearchAlejandro Marcel Hasslocher Moreno, MD MSc PhD student; Andrea Costa, MD PhD; Andrea Silvestre de Sousa, MD PhD and other collaboratorsUnknownChagas Heart DiseaseBrazil
-
Neuroscience Trials AustraliaNational Institute for Health Research, United Kingdom; Northern Ireland Chest... and other collaboratorsCompleted
-
Avita MedicalNAMSACompletedVenous Leg UlcersUnited Kingdom, France
-
University of MichiganCompleted
-
University of OklahomaCompletedTobacco Cessation | Tobacco Use | Tobacco Smoking | Smoking Cessation Financial Incentives | Socioeconomic Status | Contingency ManagementUnited States
-
University of OklahomaEnrolling by invitationTobacco Cessation | Tobacco Use | Tobacco Smoking | Smoking Cessation Financial Incentives | Socioeconomic Status | Contingency Management | PregnancyUnited States
-
Institut de Cancérologie de LorraineTerminatedBreast CancerFrance
-
University of OklahomaNational Cancer Institute (NCI)CompletedSmoking CessationUnited States
-
Indonesia UniversityCompletedCovid19 | AcupunctureIndonesia
-
brett rasmussenCompleted